NXL 8-K 2026-10-01
Nexalin Technology, Inc. (NXL) 8-K dated 2026-10-01 — accession 0001829126-26-010685.
Nexalin Technology, Inc. (NXL) is a medical devices company listed on NASDAQ.
Nexalin Technology, Inc. filed a 8-K on 2026-10-01. Accession 0001829126-26-010685.
This 8-K covers: Material agreement (Item 1.01), Reg FD disclosure (Item 7.01), Exhibits (Item 9.01). SEC EDGAR holds the official filing and its exhibits.
Latest reported NXL revenue for 2025-12-31 was $301.6K. Net income was -$8.2M. Revenue was up 78.8% from 2024-12-31 to 2025-12-31. NXL currently screens at market cap $8.5M.
Not investment advice. The NXL SEC hub lists recent forms. The stock page is the research view.